|
For immediate release |
18 May 2022 |
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Result of AGM
Alliance Pharma plc (AIM: APH), the international healthcare group, announces that, at its Annual General Meeting held earlier today, all the resolutions, as set out in the Notice of Meeting, were duly passed on a poll.
The votes were as follows:
|
RESOLUTION |
VOTES FOR |
% |
VOTES AGAINST |
% |
VOTES TOTAL |
% OF ISC VOTED |
VOTES WITHHELD |
|
|
1 |
Report and Accounts |
371,393,469 |
99.99 |
30,000 |
0.01 |
372,087,366 |
68.97 |
663,897 |
|
|
|
|
|
|
|
|
|
|
|
2 |
Final dividend |
372,086,356 |
100.00 |
0 |
0.00 |
372,087,366 |
68.97 |
1,010 |
|
|
|
|
|
|
|
|
|
|
|
3 |
Re-elect P. Butterfield |
371,812,794 |
99.94 |
238,118 |
0.06 |
372,087,366 |
68.97 |
36,454 |
|
|
|
|
|
|
|
|
|
|
|
4 |
Re-elect D. Cook |
304,867,206 |
91.75 |
27,427,589 |
8.25 |
372,087,366 |
68.97 |
39,792,571 |
|
|
|
|
|
|
|
|
|
|
|
5 |
Re-elect A. Franklin |
371,701,797 |
99.91 |
346,094 |
0.09 |
372,087,366 |
68.97 |
39,475 |
|
|
|
|
|
|
|
|
|
|
|
6 |
Re-elect R. Jones |
318,832,469 |
94.70 |
17,845,835 |
5.30 |
372,087,366 |
68.97 |
35,409,062 |
|
|
|
|
|
|
|
|
|
|
|
7 |
Re-elect J. LeCouilliard |
283,289,848 |
84.14 |
53,391,477 |
15.86 |
372,087,366 |
68.97 |
35,406,041 |
|
|
|
|
|
|
|
|
|
|
|
8 |
Elect K. Neirynck |
371,168,677 |
99.76 |
882,235 |
0.24 |
372,087,366 |
68.97 |
36,454 |
|
|
|
|
|
|
|
|
|
|
|
9 |
Re-appoint Auditor |
372,018,741 |
99.99 |
38,636 |
0.01 |
372,087,366 |
68.97 |
29,989 |
|
|
|
|
|
|
|
|
|
|
|
10 |
Remuneration of Auditor |
372,058,198 |
100.00 |
2,200 |
0.00 |
372,087,366 |
68.97 |
26,968 |
|
|
|
|
|
|
|
|
|
|
|
11 |
Allot shares |
314,847,187 |
84.62 |
57,236,109 |
15.38 |
372,087,366 |
68.97 |
4,070 |
|
|
|
|
|
|
|
|
|
|
|
12 |
Disapply Pre-emption rights |
318,400,733 |
85.57 |
53,682,363 |
14.43 |
372,087,366 |
68.97 |
4,270 |
The number of the Group's shares in issue as at the date of the meeting was 539,461,338 ordinary shares of 1p each.
Please note that each share carries one vote and that a 'vote withheld' is not a vote in law and has not been counted in the calculation of the proportion of the votes for and against the resolution. Any proxy appointments which gave discretion to the Chairman have been included in the 'votes for' total.
Chris Chrysanthou
Head of Legal & Company Secretary
18 May 2022
For further information:
|
Alliance Pharma plc |
+ 44 (0)1249 466966 |
|
Cora McCallum, Head of Investor Relations & Corporate Communications |
+ 44 (0)1249 705168 |
|
|
|
|
|
|
|
Buchanan |
+ 44 (0)20 7466 5000 |
|
Mark Court / Sophie Wills / Hannah Ratcliff |
|
|
|
|
|
|
|
|
Numis Securities Limited |
+ 44 (0)20 7260 1000 |
|
Nominated Adviser: Freddie Barnfield / Duncan Monteith |
|
|
Corporate Broking: James Black |
|
|
|
|
|
Investec Bank plc |
+ 44 (0)20 7597 5970 |
|
Corporate Finance: Daniel Adams |
|
|
Corporate Broking: Patrick Robb |
|
About Alliance
Alliance Pharma plc (AIM: APH) is an international healthcare group. Our purpose is to improve the lives of consumers and patients through making available a range of clinically valuable healthcare products.
Our core focus is on the marketing of Consumer Healthcare brands, complemented by a smaller Prescription Medicines business. In total, we hold marketing rights to around 80 brands, with revenues generated from a mix of direct, distributor and e-commerce sales.
Headquartered in the UK, Alliance employs around 250 people based in locations across Europe, North America, and the Asia Pacific region. By outsourcing our manufacturing and logistics operations, we remain asset-light and focused on maximising the value of our brands.
For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
